This week, these five stocks have the worst ratings in Earnings Momentum, one of the eight Fundamental Categories on Portfolio Grader. More
Netflix and Pay TV Are Perfect for Each Other
Cable boxes might be America's most hated device, but a tie-up between Netflix and the pay TV industry would be a watershed moment for both parties. More
6 Biotechnology Stocks to Buy Now
This week, six Biotechnology stocks are improving their overall ratings on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy"). More
10 Best “Strong Buy” Stocks — LAD CONN SNTS and more
This week, these ten stocks, all currently earning A's ("strong buy") on Portfolio Grader, have the best year-to-date performance. Since the beginning of the year, the Nasdaq is up 10.9%, the Dow rose 13.2%, and the S&P is up 12.1%. More
New Drug Could Cut ‘Bad’ Cholesterol Nearly in Half
Late stage trials of Alirocumab, an anti-cholesterol drug from Regeneron and Sanofi, showed promising results. More
IBM Earnings Could Provide a Little Push
Considering Wall Street's reserved optimism ahead of IBM earnings, bullish traders might be best off playing options spreads prior to the report. More
4 Packaged Foods Stocks to Buy Now
Four Packaged Foods stocks are moving up in their overall rating this week, according to the Portfolio Grader database. Every one of these is graded an "A" ("strong buy") or "B" overall ("buy"). More
